title: Hematopoietic stem cell transplantation for acute myeloid leukemia.
abstract: The standard treatment for de novo acute myeloid leukemia (AML) has been established. Although patients with AML achieve complete remission at high rates, the long-term prognosis for such patients remains unsatisfactory. It is therefore necessary to perform hematopoietic stem cell transplantation (HSCT) to improve their outcomes. However, a high rate of transplant-related mortality continues to be a problem associated with allogeneic HSCT. We therefore need to carefully determine the indications for safely performing HSCT based on historical data.
authors.affiliation: Department of Hematology, Kanazawa University Hospital.
authors.forename: Ken
authors.initials: K
authors.lastname: Ishiyama
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D014184:Transplantation, Homologous